Assignee
ELIAZ THERAPEUTICS INC
US·10 granted patents·4 pending applications·14 citations·filing 2013–2024
Top patents by PatentIndex Score
14 records- 0186US11389476B2Galectin-3 plasmapheresis therapyELIAZ THERAPEUTICS INC·Filed 2019·Granted Jul 19, 2022·3 cites·7 claims
- 0283US10213462B2Galectin-3 plasmapheresis therapyELIAZ THERAPEUTICS INC·Filed 2016·Granted Feb 26, 2019·3 cites·11 claims
- 0382US10828413B2Patient selective apheresisELIAZ THERAPEUTICS INC·Filed 2016·Granted Nov 10, 2020·5 cites·6 claims
- 0477US11389478B2Galectin-3 plasmapheresis therapyELIAZ THERAPEUTICS INC·Filed 2019·Granted Jul 19, 2022·1 cites·6 claims
- 0572US12551503B2Plasmapheresis therapyELIAZ THERAPEUTICS INC·Filed 2020·Granted Feb 17, 2026·0 cites·1 claims
- 0669US11389477B2Galectin-3 plasmapheresis therapyELIAZ THERAPEUTICS INC·Filed 2019·Granted Jul 19, 2022·0 cites·6 claims
- 0768US9549953B2Galectin-3 plasmapheresis therapyELIAZ THERAPEUTICS INC·Filed 2013·Granted Jan 24, 2017·2 cites·9 claims
- 0866US11141431B2Galectin-3 plasmapheresis therapyELIAZ THERAPEUTICS INC·Filed 2019·Granted Oct 12, 2021·0 cites·5 claims
- 0965US2025135079A1Method for Treating SepsisELIAZ THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1060US2021138143A1Plasmapheresis deviceELIAZ THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1157US10953148B2Plasmapheresis deviceELIAZ THERAPEUTICS INC·Filed 2014·Granted Mar 23, 2021·0 cites·14 claims
- 1253US12109346B2Galectin-3 plasmapheresis therapyELIAZ THERAPEUTICS INC·Filed 2020·Granted Oct 8, 2024·0 cites·8 claims
- 1352US2022072210A1Treatment of viral infection by apheresisELIAZ THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1439US2017035955A1Apheresis based treatment for kidney diseaseELIAZ THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ELIAZ THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →